Renal Cancer - Results from #1920

Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer. August 6, 2021

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement. August 5, 2021

Nephrometric score based on 3D modeling (3D nephrometry score) for the probability prediction of intra- and postoperative complications for kidney surgery. August 5, 2021

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study. August 4, 2021

Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab. August 4, 2021

Perioperative impact of body mass index on upper urinary tract and renal robot-assisted surgery: a single high-volume centre experience. August 3, 2021

Immunotherapy for metastatic renal cell carcinoma: A brief history, current trends, and future directions. August 3, 2021

A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma. August 2, 2021

Functional and oncological outcomes of renal surgery for hilar tumors: informing the decisions in risk-adapted management. August 2, 2021

Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era. July 30, 2021

A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. July 30, 2021

Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma. July 29, 2021

Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study. July 29, 2021

Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. July 28, 2021

Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses. July 28, 2021

Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview. July 27, 2021

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma. July 27, 2021

Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma. July 26, 2021

Rate of incisional hernia after minimally invasive and open surgery for renal cell carcinoma: a nationwide population-based study. July 26, 2021

Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma. July 23, 2021

Page 97 of 456